POSTPONEMENT PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK
We, PT Pyridam Farma Tbk., (the “Company”), would like to notify the postponement on the Public Expose that is originally planned to be electronically held on Wednesday, July 20, 2022 to become as follows: Day/Date : Thursday, July 28, 2022 Time
PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK
The Board of Directors of PT Pyridam Farma Tbk., (hereinafter referred to as the “Company”) domiciled in South Jakarta, hereby invites the shareholders to attend the Electronic Public Expose (“Public Expose”) of the Company which will be held on: Day/Date
PT Pyridam Farma Tbk Enters into a Marketing and Promotion Services Agreement with Mundhipharma Healthcare Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. Kep. 00015/BEI/01-2021 on
Prospectus of Public Offering of Pyridam Farma Bond I 2022
Wednesday, March 2nd 2022 Click to View PDF File
Additional Information of Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022
Click here to View PDF File
Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022
Click here to view PDF File
Information Disclosure of Material Transactions for Capital Increase of PT Holi Pharma
Click image to see full document
Completion of the Share Takeover Transaction at PT Holi Pharma by PT Pyridam Farma Tbk
Referring to (i) Financial Service Authority (“FSA”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, (ii) Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. KEP-00015/BEI/01-2021 on
OCBC Loans for PT Pyridam Farma Tbk and PT Holi Pharma
Click image to see full PDF
Report of Annual Rating (Obligasi Pyridam Farma I Tahun 2020)
Press Release from KRI Report of Annual Rating (PYFA)